Hologic Price to Free Cash Flow Ratio 2010-2024 | HOLX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Hologic average price to free cash flow ratio for 2024 was 19.03, a 14.51% decline from 2023.
Hologic average price to free cash flow ratio for 2023 was 22.26, a 157.04% decline from 2022.
Hologic average price to free cash flow ratio for 2022 was 8.66, a 7.28% increase from 2021.

Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Hologic average price to free cash flow ratio for 2024 was 19.03, a 14.51% decline from 2023.
Hologic average price to free cash flow ratio for 2023 was 22.26, a 157.04% decline from 2022.
Hologic average price to free cash flow ratio for 2022 was 8.66, a 7.28% increase from 2021.

Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$214.1B
Intuitive Surgical (ISRG)	$211.1B
Alcon (ALC)	$41.6B
Edwards Lifesciences (EW)	$41.2B
IQVIA Holdings (IQV)	$35.8B
IDEXX Laboratories (IDXX)	$34.3B
DexCom (DXCM)	$33B
Waters (WAT)	$24B
STERIS (STE)	$20.7B
SONOVA HOLDING (SONVY)	$19.7B
Fresenius Medical Care AG KGaA (FMS)	$13.5B
Globus Medical (GMED)	$12.4B
Sysmex ADR (SSMXY)	$11.7B
Penumbra (PEN)	$10.1B
Masimo (MASI)	$9.2B
Glaukos (GKOS)	$8.6B
Teleflex (TFX)	$8.4B
Integer Holdings (ITGR)	$4.7B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$4B
Veracyte (VCYT)	$3.1B
Nihon Kohden (NHNKY)	$2.7B
LivaNova (LIVN)	$2.6B
Tandem Diabetes Care (TNDM)	$2.3B
Elekta AB (EKTAY)	$2.2B
TransMedics (TMDX)	$1.9B
Integra LifeSciences Holdings (IART)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
RxSight (RXST)	$1.2B